We used 21 monoclonal antibodies (PAbs 100 to 117, 405, 419, and KT3) specific for different determinants in simian virus 40 (SV40) large T antigen (T) and one antibody specific for p53 that coprecipitates T complexed with p53 (T-p53) to analyze T in SV40-infected CV1 cells. We measured the ATPase specific activity, extent of adenylylation, and p53 content of T precipitated by antibodies directed against the N-terminal region I (0.65 to 0.62 map units), the midregion III (0.43 to 0.28 map units) containing both the ATPase-and nucleotidebinding sites, and the C-terminal region IV (0.28 to 0.17 map units) of T. Lytic T appeared to exist in three different forms with respect to p53 binding and ATPase activity. The most ATPase-active form of T was that precipitated by PAb 122. This T-p53 complex contained only 6% of the total T but contributed 35% of the ATPase activity, on average. Free p53 isolated from 3T6, Ann-1, or L929 cells had no apparent ATPase activity. A second form of T precipitated by several antibodies had little associated p53 but appreciable ATPase activity, accounting for 15 to 20% of total T and 60 to 70% of the ATPase activity. The rest of T constituted the third form and was also depleted in p53 but had a decreased ATPase specific activity. Thus, the remaining 75 to 80% of T had 15 to 20% of the ATPase specific activity. Antibodies specific for region III precipitated T with both altered ATPase activity and altered amounts of bound p53. PAbs 104 and 114 reacted with ATPase-active T but inhibited ADP hydrolysis, suggesting that they were inactivating antibodies. T that was preferentially adenylylated in vitro corresponded to T that was also preferentially ATPase active. T bound to p53 was adenylylated to a higher specific activity than total T. In addition, p53 itself was significantly adenylylated under these conditions. The results suggest that ATPase activity and p53 binding are structurally and functionally related and that p53 alters biochemical activities of T and plays a role in productive infection.
Simian virus 40 (SV40) large T antigen (T) can transform cells and is required to initiate viral DNA replication (for reviews, see references 9 and 38). T appears also to function during elongation of replicating SV40 DNA molecules by synchronizing replication fork movement (35) . T has an intrinsic ATPase activity (12, 37) that appears necessary for SV40 replication (5, 23) . Indeed, T contains a sequence centered at residue 432 that is highly homologous with the nucleotide-binding region of the procaryotic recA protein, a promoter of DNA strand exchange and also an ATPase (29, 30) . Covalent modification of T after incubation with the affinity label dialdehyde-ATP affects T-dependent ATPase and in vitro SV40 DNA replication activities; up to a 1:1 stoichiometry of binding of dialdehyde-ATP to T antigen was observed (7, 9, 31) . The site of adenylylation is located between residues 412 and 528 in T (8) . Direct adenylylation of T with unmodified ATP has also been reported; less than 5% of T was modified (2) . Here, the peptide-bound moiety was AMP covalently linked to the protein via a phosphodiester bond to a serine residue, putatively Ser-430 (2, 9) . Mutations affecting replication map near the putative adenylylation site, suggesting that adenylylation is important for viral DNA synthesis. While the ATPase site has been reported to be distinct from the nucleotide-binding site (8) , interaction between the two sites appears necessary for DNA replication (31) . A transformation-related cellular pro-* Corresponding author.
tein, 53 kilodaltons in size, is physically associated with SV40 T in SV40-infected and -transformed cells (13, 14, 18, 21) . p53 appears to be required for cellular DNA synthesis and may regulate cell proliferation (24, 25, 27) .
Recently, several new hybridoma lines synthesizing papovavirus-specific monoclonal antibodies (PAbs 100 to 117) specific for three different antigenic regions of T were described (15) . A map of the binding sites in T for these and other antibodies has been compiled (4, 6, 10, 15, 17) . We and others have used these T-specific antibodies as probes to identify and characterize structurally and functionally distinct forms of SV40 T and to analyze changes in specific regions as well as interactions between domains in wild-type T proteins. These studies have indicated the presence of different forms of T, including old compared with newly synthesized T (3, 14) , forms more active in a DNA-binding assay (28) , and those that are free or associated with replicating or with mature SV40 chromosomes (36) . Analysis of the relative amounts of T in various subcellular fractions indicated that about 1.3% of total T is associated with SV40 chromosomes in infected cells (36) .
In this study, we used PAbs 100 to 117, 405, 419, and KT3 (14, 15, 17, 22) to further characterize and quantify both structurally and functionally distinct forms of T prepared from productively infected CV1 cells. In addition, we used the monoclonal antibody PAb 122 (14) , specific for p53, to study T complexed with p53 (designated T-p53). A hypotonic fractionation procedure was used since viral nucleoprotein complexes prepared by this procedure are competent ATPase-ACTIVE SV40 T ANTIGEN-p53 COMPLEXES 1029 to replicate and transcribe faithfully in an in vitro system (32, 33) . For all assays, specific activities were determined so that differences that were due to antibodies recognizing different subclasses of T could be distinguished from those reacting with T with low affinity. T bound to p53 was both preferentially ATPase active and adenylylated in vitro and had several determinants altered in region III of the Tantigen molecule. This identification of enhanced biochemical activities important for SV40 DNA replication that are associated with the T-p53 complex is evidence that p53 may have an important function in SV40 productive infection.
MATERIALS AND METHODS Cells and virus. CV1 cells and SV40 strain wt800 viral stocks were grown as previously described (32) . Each 150-mm dish of SV40-infected cells was radiolabeled in vivo with 1 mCi of [35S]methionine (1, 250 Ci/mmol; Amersham Corp., Arlington Heights, Ill.) in 10 ml of Dulbecco modified Eagle medium (0.2x methionine) plus 3% dialyzed fetal calf serum for 12 to 17 h. At 36 to 42 h postinfection, cells were lysed by hypotonic extraction as previously described (32, 34) . The hypotonic buffer consisted of 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (pH 7.8), 5 mM KCI, 0.5 mM MgCl2, and 1 mM dithiothreitol. The cell lysate was pelleted by centrifugation at 20,000 x g for 45 min. Under these conditions, the supernatant fraction contained about 80% of the total T present in the cell and was used for further analysis. On average, about 600 ,ul of extract was obtained from each 150-mm dish.
Immunosorption. Hybridoma supernatant PAbs 100 to 117, 405, 419, and KT3, all specific for large T, and PAb 122, specific for p53, were prepared as previously described (14, 15, 17, 22 min) were subtracted. Antibodies were compared with one another when ADP production was proportionate to time, usually at 30 min. For each antibody measured, the relative ATPase specific activity was determined by normalizing the rate of ATP hydrolysis to the amount of T present in that immune complex after SDS-gel electrophoresis and beta-scan analysis of the dried gel. Using PAb 108 and various concentrations of cell extract, we found that the ATPase activity was proportionate to the amount of T bound to the immune complexes; the different antibodies were compared in this range of T concentration. Protein A-Sepharose-purified monoclonal antibodies gave the same results as hybridoma supernatants.
The ATPase activity of T fractions prepared by sequential and mixed immunoprecipitations was also measured. Sequential immunosorption involved first reacting cell extracts with saturating amounts (two rounds) of a given antibody and protein A followed by protein A beads alone to completely remove all of the first antibody. The supernatant was then reacted with a second antibody and protein A. The washed pair of immune complexes (precipitate PAb 1 and supernatant PAb 1 precipitated with PAb 2) were then assayed in parallel to measure the relative amount of ATPase activity normalized to the amount of labeled T present in each precipitate. Mixed immunosorptions consisted of first reacting extracts with a specific antibody (usually PAb 108 or 122) and washing. Then, saturating amounts of a second antibody were added to the complex, incubated, and (2) .
RESULTS
Relative reactivity of each monoclonal antibody with T. The locations of the recognition sites in T for PAbs 100 to 117, 405, 419, and KT3 are shown in Fig. 1 . All precipitate T from extracts of SV40-infected monkey cells (15, 17, 22) . The locations of sequences in T known to contain the specific DNA-binding (residues 135 to 230), nucleotide-binding (residues 412 to 528), recA-homologous (centered at residue 432), ATPase (residues 371 to 628), and putative adenylylation (residue 504) sites are also shown (2, 4, 5, 8, 9, 30; J. Pipas, personal communication). PAb 122 specifically recognizes the C terminus of p53 and coprecipitates T complexed with p53 (13, 14, 18, 21) .
The fraction of total T reactive with these antibodies was measured by protein A-dependent immunoprecipitation as described in Materials and Methods. In general, hybridoma supernatants were used since affinity-purified antibodies gave the same result but were unstable on storage (36) . When necessary, a second antibody was added to the reactions. The immune complexes were fractionated by SDS-gel electrophoresis; representative gels are shown in Table 1 .
The results were reproducible and consistent with those previously obtained for PAbs 100 to 109 under these conditions (36) , that is, antibodies specific for determinants located in region I of T precipitated at least 60% of the T normally reactive with polyclonal tumor serum. By this criterium, PAbs 108 and 109 consistently precipitated essentially 100% of the T. All region III antibodies precipitated significantly less T, from 4 to 43%. Four of the five region IV antibodies precipitated 60 to 80% of the T; one (PAb 115) reacted with only 35% of the T. Thus, all but one determinant in the N-and C-terminal regions of T were highly reactive with their corresponding antibodies, while all determinants in region III appeared significantly less reactive in free T. We have previously shown that the PAbs 102, 103, 104, and 106 region III are highly reactive with the form of T bound to replicating SV40 chromosomes (36) . Therefore, the low extent of reactivity of these antibodies with free T is likely due to inaccessibility of the epitopes rather than poor binding by the antibodies.
Relative T/p53 ratio for each antibody. relative radiolabel content. Since both T and p53 contain a similar number of methionines per 100 amino acids, this roughly corresponds to a molar T/p53 ratio of 6.
The labeled T/p53 ratio for antibodies specific for region I and region IV was similar to this. However, several region III antibodies behaved differently, with PAbs 103, 104, 106, and 114 recognizing T that was two-to threefold deficient in p53. In contrast, PAb 100 in region III appeared to recognize T that was about two-to threefold enriched in associated p53. PAb 122 (anti-p53) precipitated 6% of the 16-h-labeled T and 4% of 4-h-labeled T, on average. Essentially 90% of labeled monkey p53 is associated with T under these conditions (precipitable with PAb 108 which reacts with total T). With PAb 122, there was an approximately equal ratio of labeled T and p53. From this, we estimate that the molar ratio of T/p53 in the complex reactive with PAb 122 is about 0.5. The p53-specific antibody PAb 246 (39) was also tested, but it precipitated less than 10% of the total monkey p53 compared with that recognized by PAb 122.
These results suggest that the fraction of T precipitated by most antibodies has the same relative amount of bound p53 as total T. Thus, region I-and IV-specific antibodies appear to see similar forms of T as tumor serum. However, several region III-specific antibodies bound T fractions with altered amounts of bound p53. Four antibodies preferred T that was depleted in bound p53; possible explanations for this include blocking of these epitopes by bound p53 or the presence of distinct subclasses of T with respect to bound p53.
Relative ATPase activity of immune-complexed T. Since many antibodies reacted with less than total T, some precipitated fractions may represent subclasses of T. Also, many antibodies were specific for regions III or IV containing the ATPase domain; some might directly react with elements of the ATPase site. Accordingly, we measured the ATPase activity of T precipitated with the antibodies as described in Materials and Methods. Typical chromatograms of radiolabeled ATP and ADP (the primary hydrolysis product) are shown in Fig. 3 . The rate of conversion (nanomoles per minute) for each immune-complexed T fraction was measured. The specific activity was determined by normalizing the ATPase activity to the amount of [35S]methionine-labeled T found in the same immunoprecipitation fraction. The results shown in Table 1 are averages of at least 10 separate ATPase determinations for each antibody. Since PAb 108 immunoprecipitates nearly all the T reactive with polyclonal tumor anti-T serum, its activity (units of ATP hydrolyzed) and relative amount of T present were both made equal to 1.0. The hydrolysis rate for PAb 108-complexed total T was approximately 12 nmollmin per mg of protein, similar to that previously reported for purified free D2 T antigen (4).
The most surprising result was obtained with PAb 122, which precipitated a small (6%) fraction of T bound to P53 but accounted for up to 40% of the total ATPase activity (T reactive with PAb 108). At 2 ,uM ATP, the specific activity of T-p53 complexes was 7.5 times, on average, that-of total T. This enhanced ATPase activity was also observed at ATP concentrations of up to 100 ,uM. To determine whether this increased ATPase activity was not due to the presence of an ATPase activity associated with P53 itself, we assayed hypotonic extracts of Ann-1, L929, and 3T6 cells, all containing free p53 (13; L. Tack, personal observation). Analysis of the p53 present in 3T6 extracts and immunoprecipitable with PAb 122 is shown in Fig. 4A . No detectable ATPase activity was associated with immune-complexed p53 protein in the absence of T (Fig. 4B) ; equal amounts of free p53 and p53 complexed to T were assayed in parallel.
While the absolute ATPase activities were different for T precipitated with some antibodies (Fig. 3) , the specific activities for many were similar. In general, region I-specific antibodies precipitated most of T and had ATPase specific activities similar to that of PAb 108. However, PAbs 111 and 116 appeared to precipitate T that was slightly enriched in ATPase activity. Several region III-specific antibodies (PAbs 100, 103, and 106) precipitated T that was up to threefold enhanced in ATPase specific activity. PAb 106 precipitated between 40 and 60% of total T; at the lower concentration of T, the ATPase specific activity was higher than when more T was present. PAbs 104 and 114 precipitated T with a highly reduced ATPase specific activity (about three-to fourfold, on average). However, PAb 102 precipitated T with the same ATPase specific activity as total T. Most of the region IV-specific antibodies were like those specific for region I: T was precipitated with an ATPase activity similar to that of total T. PAbs 107 and 115 precipitated T that was slightly ATPase active, reacting with 35 to 67% of total T.
These results indicate that four antibodies specific for region III reacted with forms of T that showed the greatest change in ATPase activity. Two the ATPase activity was consistently twofold more inhibited for T depleted in p53 than for T-p53. Thus, PAbs 104 and 114 appear to preferentially inhibit T depleted in p53; they also appear to inhibit, but less strongly, the ATPase activity of T-p53 complexes. When PAbs 103, 106, and 122 were added to PAb 114-precipitated T, no change in ATPase activity was observed, consistent with the presence of active forms of T rather than activating antibodies.
Sequential immunoprecipitation allows separation of total T into different fractions which can be assayed in parallel for ATPase activity. The data for these analyses are shown in Table 3 . For PAb 108, about 90% of the T was precipitated in the first round with a specific activity of 1.0; when PAb 108 was used in the second round, the remaining T also had a specific activity of 1.0. In contrast, precipitation first with either PAb 104 or 114 followed by precipitation of supernatant T with PAb 108 resulted in a depletion of ATPase specific activity for the remaining T. This is consistent with recognition and inactivation of an ATPase-active subclass of T subsequent to antibody binding. When PAb 104 or 114 was followed by PAb 122, about half of the ATPase activity usually associated with T-p53 remained; thus, PAbs 104 and 114 bind to some but not all of the ATPase-active T. When T was sequentially reacted with PAb 103, 106, or 115 and then with PAb 108, the remaining T was depleted in ATPase activity. This is consistent with these PAbs preferring an ATPase-active form of T. PAbs 103, 106, and 115 each precipitate about 30 to 40% of the T, on average. Sequential precipitation with PAb 100 followed by PAb 122 resulted in a decrease in activity for the PAb 122 precipitate. This is consistent with PAb 100 recognizing some of the ATPaseactive T-p53 normally precipitated by PAb 122 (Table 1) . There was no detectable change in ATPase activity for the PAb 108 precipitate after reacting with PAb 100; however, since PAb 100 binds such a small amount of total T (less than 5%), a significant difference was not expected. When PAb 122 was followed by PAb 100, the specific activity was still high, indicating that the form of T lacking p53 present in the PAb 100 fraction of T also has enhanced ATPase activity. Thus, the T-p53 recognized by PAb 100 does not account for all the elevated ATPase activity of th-is fraction. The reverse experiment with PAb 100 followed by PAb 122 showed that some but not all of the ATPase-active T-p53 is recognized.
These results suggest that there are different forms of T with altered ATPase activity. T-p53 accounted for 5% of the total T and 30 to 40% of the total activity and thus was preferentially ATPase active. There appeared to be two forms of T without p53. One consisted of about 15 to 20% of the T and about 60% of the ATPase activity, suggesting another enhanced ATPase-active subclass. This form was recognized best by PAbs 104 and 114. PAbs 100, 103, 106, and 115 also appeared to react with this form of T. The other form of T lacking p53 is inferred to be significantly less ATPase active and appears to consist of the remaining T (75% of the total) with about 10 to 15% of the ATPase activity. Two PAbs (104 and 114) appeared to recognize an ATPase-active form of T but were inactivating upon binding; these antibodies preferred to bind T without p53 than to bind T-p53. Kinetic (Lineweaver-Burk) analysis indicated that the Vmax for ATP hydrolysis for total T of 12 nmol/min per mg of T decreased to 1.5 to 2.0 nmol/min per mg of T for total T with added PAb 104 or 114; the Km was relatively unaffected (data not shown). No activating antibodies were observed for ATPase activity. PAb 100 appears to bind an ATPase-active form of T, some of which is associated with p53.
In vitro adenylylation. Bradley and co-workers (2) have observed that a small fraction of purified SV40 T is adenylylated in vitro when incubated with labeled ATP. Accordingly, we incubated immune-complexed T with [ot-32P]ATP as described in Materials and Methods. Figure 5 shows the results when T and T-p53 complexes were immunoprecipitated with different antibodies (PAbs 105 to 110 and 122) and incubated with labeled ATP. The labeled immune complexes were fractionated on SDS gels and analyzed by autoradiography. After extraction of the at-32P-labeled T band from the dried gel, digestion with snake venom phosphodiesterase generated [32P]AMP. Acid hydrolysis of the extracted labeled T band generated [32P]phosphoserine. Alkaline phosphatase had no effect on the amount of specific 32p incorporation into T. These results are all consistent with in vitro adenylylation of immune-complexed T. We observed that labeled ATP incorporation into T was linear with increasing ATP concentration, up to 1 mM, as reported previously (2); however, the degree of nonspecific adenylylation of T increased at greater than 50 ,uM concentrations of ATP, when (Fig. 3) 36) . This suggests that T bound to both forms of chromatin has ATPase activity. Most of region III is sensitive to both SDS and thermal denaturation (6, 15) ; thus, specific antigenic sites within this region could affect the overall structure of T rather than directly interacting with the ATPase active site. The oligomerization of T may also affect its reactivity with a given antibody since T from lytically infected cells is predominantly tetrameric (14 to 16S) in structure (1, 11) . Monomer units of T within this complex may be arranged such that a particular region is shielded resulting in poor reactivity with a corresponding antibody. It is also possible that all four potential binding sites are not equally reactive with a given antibody; however, as long as one is accessible, the tetrameric protein could bind efficiently to the antibody. Summary. That T-p53 complexes are preferentially ATPase active and adenylylated, activities that are both associated with SV40 replication, is significant. This observation suggests a role for T-p53 in productive infection, perhaps in regulating ATPase activity. Bound p53 may protect enhanced ATPase-active forms of T with increasing age or oligomerization of the T. The significance of p53 adenylylation is unclear. A small fraction of T is adenylylated in cells, but a similarly small fraction of the total T in cells is bound to replicating SV40 chromosomes (36) . We are further characterizing the reactivity of these antibodies toward other forms of T and T-p53 complexes of different age and degree of oligomerization. We are also measuring the reactivity of specific mutant T antigens toward different antibodies and comparing the results with that of wild-type T. In this way, we can determine whether a localized alteration or a broad conformational change is responsible for particular defects in T functions and better characterize the structural and functional correlates of the various forms of T present in lytically infected cells.
